Urinalysis Market

The report "Urinalysis Market by Product (Consumables [Disposable, Reagents],Instruments [Automated, Microscopy, PoC]), Test Type (Pregnancy, Sediment), Application (UTI, Diabetes, CKD), Technology (Biochemical), End User (Hospital) & Region -Global Forecast to 2031" is expected to reach USD 7.16 billion by 2031 from an estimated USD 4.88 billion in 2026, at a CAGR of 8.0% during the forecast period.

Browse 490 market data Tables and 50 Figures spread through 430 Pages and in-depth TOC on "Urinalysis Market, by Product (Consumables [Disposable, Reagents],Instruments [Automated, Microscopy, PoC]), Test Type (Pregnancy, Sediment), Application (UTI, Diabetes, CKD), Technology (Biochemical), End User (Hospital) & Region -Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/urinalysis-systems-market-153479294.html

The urinalysis market is growing steadily, driven by the rising prevalence of urinary tract infections (UTIs), diabetes, kidney diseases, and liver diseases worldwide. The growing geriatric population and the associated rise in age-related disorders are further increasing demand for routine urine testing for disease screening, diagnosis, and monitoring. Additionally, advances in automated urine analyzers, digital microscopy, flow cytometry, and integrated urinalysis systems are improving the accuracy, efficiency, and throughput of urine testing. The growing emphasis on preventive healthcare, early disease detection, and point-of-care (PoC) testing, along with rising healthcare spending in emerging economies, further supports market growth. However, the availability of refurbished urine analyzers, the high costs of advanced automated systems, and limited access to sophisticated diagnostic infrastructure in developing regions may, to some extent, restrain market growth.

By product, the consumables segment held the largest share in the urinalysis market in 2025.

By product, the urinalysis market is segmented into consumables and instruments. The consumables segment held the largest market share in 2025, primarily due to their recurring use and frequent replacement needs. Products such as pregnancy and fertility kits, dipsticks, reagents, and disposables are required for routine urinalysis testing, resulting in continuous demand across hospitals, diagnostic laboratories, clinics, and home care settings. The wide availability of consumables for different testing requirements and the growing volume of urine-based diagnostic tests further support the segment’s leading position.

In 2025, the pregnancy & fertility tests segment held the largest share in the urinalysis market.

By test type, the urinalysis market is segmented into biochemical tests, sediment urinalysis, and pregnancy & fertility tests. The pregnancy & fertility tests segment accounted for the largest market share in 2025, supported by growing awareness of reproductive health and family planning, particularly in developing countries. Technological advancements have improved the accuracy, ease of use, and speed of these tests, while the availability of convenient home-based testing and rapid results has further increased their adoption. Ongoing product innovation and R&D investments by key market players are also contributing to the expansion of this segment.

North America is the largest regional market for urinalysis.

The urinalysis market is segmented into five key regions, namely North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2025, North America accounted for the largest share of the urinalysis market. The region’s well-established healthcare infrastructure, advanced diagnostic facilities, and skilled healthcare workforce support the widespread integration of urinalysis into routine clinical practice. The high adoption of advanced diagnostic technologies, including automated urine analyzers and other sophisticated urinalysis systems, further contributes to market growth. In addition, the high prevalence of chronic conditions such as diabetes, kidney diseases, and urinary tract infections increases the need for regular urine testing for disease screening, diagnosis, and monitoring, supporting the region’s leading market position.

The major players in this market include Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Cardinal Health (US), Sysmex Corporation (Japan), Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Abbott (US), Bio-Rad Laboratories, Inc. (US), QuidelOrtho Corporation (Japan), and Waters Corporation (US), among others.

Don’t miss out on business opportunities in Urinalysis Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com